Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Gastric cancer is a malignant tumor of the gastric mucosa, commonly occurring in middle-aged and elderly people, especially patients over 50 years old. Treatment methods are diverse, covering surgery, chemotherapy, radiotherapy, immunotherapy, and minimally invasive techniques. If treatment is missed, cancer cells can easily spread and metastasize, severely affecting prognosis and survival. Proper treatment is crucial for controlling the disease and prolonging life.
Immune reconstruction cell therapy strengthens the patient’s own immune function, helping to identify and eliminate cancer cells, effectively improving treatment outcomes and quality of life.
① Activates T cells and natural killer cells, enhancing the killing effect on tumor cells;
② Reduces side effects of traditional therapies, improving patient tolerance;
③ Applicable to multiple stages of gastric cancer, especially advanced and recurrent cases.
In actual treatment, cancer patients undergoing surgery, radiotherapy, and chemotherapy often face immune function damage, increased infection risk, and slow recovery. To better support patients during treatment, improve tolerance, and enhance survival and quality of life, it is necessary to scientifically develop staged immune reconstruction programs for different treatment cycles.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion to boost the effectiveness of anti-cancer treatment.
● Mid-term plan: Reduce side effects of traditional therapies, promote recovery, and ensure completion of standard treatment courses.
● Long-term plan: Improve overall immunity through immune cell reconstruction, intestinal immunity reconstruction, elemental immunity reconstruction, and immune nutrition reconstruction, thereby enhancing quality of life and extending survival.
1. Surgical treatment
Surgery is the main curative approach for gastric cancer, suitable for early and intermediate-stage patients. With technological progress, minimally invasive procedures such as laparoscopic surgery are increasingly applied, providing less trauma, faster recovery, and fewer postoperative complications.
2. Chemotherapy
Chemotherapy is used to shrink tumors before surgery, as adjuvant therapy after surgery, and for control in advanced stages. Common drugs include fluorouracil and cisplatin. Combining chemotherapy with targeted drugs can improve effectiveness.
3. Radiotherapy
Radiotherapy is often used for local control or as adjuvant therapy after surgery. Intensity-modulated radiotherapy precisely targets tumors, minimizing damage to surrounding healthy tissues and improving local control rates.
4. Minimally invasive treatment
Endoscopic resection of early gastric cancer and radiofrequency ablation provide treatment options with less trauma and faster recovery for some early-stage patients, and their use is becoming increasingly widespread.
5. Targeted therapy
Targeted therapy blocks tumor growth signals based on specific molecular markers, suitable for patients with positive gene mutations, and is usually combined with chemotherapy.
Experts from the United Life International Medical Center remind that gastric cancer treatment should adopt a multidisciplinary comprehensive approach, integrating immune reconstruction cell therapy and modern minimally invasive techniques to achieve personalized and precise treatment. Early diagnosis and treatment are of great significance in improving survival and quality of life, and patients should actively cooperate with doctors for scientific treatment.
